The President and CEO of the company Evangelos Zekkas in his speech in clinical research Conference, held at the Convention Center of National Insurance on 15 & 16 of January 2014 about “clinical research dynamic growth driver for Greece” highlighted the key beneficial points of economy as summarized below:

• Faster patient access to innovative formulations and treatment protocols with well-established and old formulations
• Familiarity of Medical & Pharmaceutical staff in the latest technologies
• Utilization of the scientific potential of our country, whether it comes from the field of medicine or the pharmaceutical field
• State funding for nursing and institutions.
• Attracting of new domestic and international investment interest.